Search Results 381-390 of 16389 for infliximab

  1. A Study Of Ifinatamab Deruxtecan In Subjects With Pretreated Advanced Or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01) - Mayo Clinic

    A Study Of Ifinatamab Deruxtecan In Subjects With Pretreated Advanced Or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01) · Overview.

  2. shingles Archives - Mayo Clinic News Network

    ... infliximab (Remicade), etanercept (Enbrel), radiation or chemotherapy; Have cancer that affects the bone marrow or lymphatic system, such as leukemia or ...

  3. Darunavir, cobicistat, emtricitabine, and tenofovir alafenamide (oral route) - Side effects & dosage - Mayo Clinic

    This may help delay problems that are usually related to AIDS or HIV disease from occurring. This medicine will not keep you from spreading HIV to other people.

  4. Everolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    Everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Brentuximab vedotin may interfere with the ability of ...

  5. A Study To Evaluate Abatacept To Treat Giant Cell Arteritis - Mayo Clinic

    Patients who have been treated within 4 weeks of randomization with etanercept or within 8 weeks with adalimumab, certolizumab, golimumab, or infliximab.

  6. Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving selinexor, carfilzomib, and dexamethasone may be ...

  7. Ombitasvir, paritaprevir, ritonavir and dasabuvir (oral route) - Side effects & dosage - Mayo Clinic

    This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Tablet. Back to top ...

  8. Cancer Treatment Clinical Trials - Mayo Clinic Research

    The purpose of this study is to assess the safety and effectiveness of Avutometinib combined with adagrasib in patients with G12C Non-Small Cell Lung Cancer ( ...

  9. S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma - Mayo Clinic

    Carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as dexamethasone, work ...

  10. A Study to Evaluate IMGN632 with Venetoclax and/or Azacitidine to Treat Patients with CD123-Positive Acute Myeloid Leukemia - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...